Clopidogrel bisulfate (Plavix) does not increase bleeding complications in patients undergoing rubber band ligation for symptomatic hemorrhoids

Journal of Surgical Research

Volumn 229, Issue , 2018, Pages 230-233

  Hite, N ^a   Klinger, A L ^b   Miller, P ^c   Beck, D E ^b,d   Whitlow, C B ^b,d   Hicks, T C ^b   Green, H M ^b   Margolin, D A ^b,d  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c Colon and Rectal Specialists Ltd ^*  (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bleeding complication; Clopidogrel; Hemorrhoids; Rubber band ligation

Indexed keywords

CLOPIDOGREL; RUBBER; ANTITHROMBOCYTIC AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING DISORDER; BLOOD TRANSFUSION; CASE CONTROL STUDY; CAUTERIZATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; COLONOSCOPY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEMORRHOID; HOSPITAL ADMISSION; HOSPITAL CARE; HUMAN; LIGATION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RUBBER BAND LIGATION; TERTIARY HEALTH CARE; TREATMENT INDICATION; INCIDENCE; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PROCEDURES; RECURRENT DISEASE; THROMBOSIS; TREATMENT OUTCOME;

AGED; CLOPIDOGREL; FEMALE; HEMORRHOIDS; HUMANS; INCIDENCE; LIGATION; MALE; PERIOPERATIVE PERIOD; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; RECURRENCE; RETROSPECTIVE STUDIES; THROMBOSIS; TREATMENT OUTCOME;

EID: 85046703536     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2018.04.004     Document Type: Article

References (15)

1. Singer, M.A., Hemorrhoids. Beck, D.E., (eds.) The ASCRS Manual of Colon and Rectal Surgery, 2014, Springer, New York, 211–234.
2. Rivadeneira, D.E., Steele, S.R., Ternent, C., Chalasani, S., Buie, W.D., Rafferty, J.L., Practice parameters for the management of hemorrhoids (revised 2010). Dis Colon Rectum 54 (2011), 1059–1064.
3. Bat, L., Melzer, E., Koler, M., Dreznick, Z., Shemesh, E., Complications of rubber band ligation of symptomatic internal hemorrhoids. Dis Colon Rectum 36 (1993), 287–290.
4. Iyer, V.S., Shrier, I., Gordon, P.H., Long-term outcome of rubber band ligation for symptomatic primary and recurrent internal hemorrhoids. Dis Colon Rectum 47 (2004), 1364–1370.
5. Pigot, F., Juguet, F., Bouchard, D., Castinel, A., Do we have to stop anticoagulant and platelet-inhibitor treatments during proctological surgery?. Colorectal Dis 14 (2012), 1516–1520.
6. Pigot, F., Juguet, F., Bouchard, D., Castinel, A., Vove, J.P., Prospective survey of secondary bleeding following anorectal surgery in a consecutive series of 1,269 patients. Clin Res Hepatol Gastroenterol 35 (2011), 41–47.
7. Oprea, A.D., Popescu, W.M., Perioperative management of antiplatelet therapy. Br J Anaesth 111 (2013), i3–i17.
8. Zakarija, A., Bandarenko, N., Pandey, D.K., et al. Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke 35 (2004), 533–537.
9. Marshman, D., Huber, P.J. Jr., Timmerman, W., Simonton, C.T., Odom, F.C., Kaplan, E.R., Hemorrhoidal ligation. A review of efficacy. Dis Colon Rectum 32 (1989), 369–371.
10. Nelson, R.S., Ewing, B.M., Ternent, C., Shashidharan, M., Blatchford, G.J., Thorson, A.G., Risk of late bleeding following hemorrhoidal banding in patients on antithrombotic prophylaxis. Am J Surg 196 (2008), 994–999 discussion 999.
11. Beattie, G.C., Rao, M.M., Campbell, W.J., Secondary haemorrhage after rubber band ligation of haemorrhoids in patients taking clopidogrel–a cautionary note. Ulster Med J 73 (2004), 139–141.
12. Iakovou, I., Schmidt, T., Bonizzoni, E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005), 2126–2130.
13. Sibon, I., Orgogozo, J.M., Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology 62 (2004), 1187–1189.
14. Serebruany, V.L., Midei, M.G., Meilman, H., Malinin, A.I., Lowry, D.R., Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial. Int J Clin Pract 60 (2006), 863–866.
15. Cohen, M., Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care. Mayo Clinic Proc 84 (2009), 149–160.